Vicarious Surgical News

Buy Rating Affirmed: Vicarious Surgical's Advancements Poised to Disrupt Medical Robotics

TipRanksMar 13 02:15 ET

A New Cause for Concern: Vicarious Surgical Inc. Adds a New Share Price & Shareholder Rights Risk

TipRanksMar 6 01:01 ET

Vicarious Surgical Analyst Ratings

BenzingaMar 5 09:02 ET

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Vicarious Surgical (RBOT) and 89bio (ETNB)

TipRanksMar 4 19:02 ET

BTIG Sticks to Their Hold Rating for Vicarious Surgical (RBOT)

TipRanksJan 7 05:47 ET

BTIG Sticks to Their Hold Rating for Vicarious Surgical (RBOT)

TipRanksJan 2 09:49 ET

Morgan Stanley Initiates Coverage On Vicarious Surgical With Equal-Weight Rating, Announces Price Target of $0.6

BenzingaDec 4, 2023 08:02 ET

Vicarious Surgical Analyst Ratings

BenzingaDec 4, 2023 08:00 ET

Canaccord Cuts Vicarious Surgical to Hold, Cites Timelines Delays

Seeking AlphaNov 15, 2023 15:33 ET

Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Evogene (EVGN)

TipRanksNov 14, 2023 08:50 ET

Piper Sandler Keeps Their Hold Rating on Vicarious Surgical (RBOT)

TipRanksNov 14, 2023 07:36 ET

Canaccord Genuity Downgrades Vicarious Surgical to Hold, Lowers Price Target to $0.4

BenzingaNov 14, 2023 06:10 ET

Vicarious Surgical Analyst Ratings

BenzingaNov 14, 2023 06:05 ET

BTIG Downgrades Vicarious Surgical (RBOT) to a Hold

TipRanksNov 14, 2023 05:47 ET

BTIG Reaffirms Their Buy Rating on Vicarious Surgical (RBOT)

TipRanksOct 16, 2023 05:46 ET

Vicarious Surgical (RBOT) Receives a Hold From Piper Sandler

TipRanksJul 28, 2023 08:46 ET

Piper Sandler Remains a Hold on Vicarious Surgical (RBOT)

TipRanksMay 9, 2023 07:51 ET

BTIG Remains a Buy on Vicarious Surgical (RBOT)

TipRanksMay 8, 2023 21:56 ET

BTIG Sticks to Its Buy Rating for Vicarious Surgical (RBOT)

TipRanksFeb 13, 2023 19:50 ET

BTIG Remains a Buy on Vicarious Surgical (RBOT)

TipRanksDec 6, 2022 16:40 ET